EPharmacy Workshop 9 June 2008-Minutes

---

Under Construction

---

Venue

• Brussels, 9 June 2008 from 10-17hr

Participants

• Belgium : V. Hayen (KLAV)
• France : J. Surugue (EAHP), F. Gener (Phast), S. Letellier (EAHP/Phast), J. Nies (Medasys), E. Serrot (Vidal), S. Juvin (GIP-DMP), C. Rica (GIP-DMP), K. Bourquard (Gmsih), J. Nies (Tedasys)
• Greece : L. Tzimis (EAHP)
• Netherlands : M. Sprenger(NICTIZ), R. Moss (EAHP)
• Spain : Juan Nunez(Indra)
• IHE Eur : G. Claeys (Agfa Healthcare)

All Documents

• Ftp site : ftp://ftp.ihe.net/International/Europe/Development/Pharmacy/Meetings/Meeting9June2008/
• Zip archive: here

Community pharmacy Use Cases

• Document : IHE Pharmacy Community Use Cases v01
• Assumption :
  • Community pharmacy Use Cases and transactions will be aligned with IHE XDS Use Cases/ transactions :
  • Document centric actors : prescripton provider
• Feedback :
  • Terminology : use IHE terms where appropriate : e.g. prescription repository instead of prescription registry); name an actor by their role and not by their implementation (e.g. IT infrastructure provider instead of college of pharmacists; prescription producer instead of prescription modules, …)
  • Security : add security mechanisms (authentications, auditing, encryption) in the sequence diagrams
  • Domain model :
    • Prescription attributes : Medication (dose, frequency, instruction), optional : symptions, diagnosis
    • Dispensed medication attributes: dispensed medication, link to original prescription.
  • Future work (>2009)
    • Define the complete business process for e*pharmacy as a basis for identifying the critical use cases
    • Create Prescription (as part of CPOE) which contains transactions to drug database
  • Actions :
    • All : send the minimal set of prescription/dispensed medication attributes that are required for a particular country to Juan Nunez

Hospital pharmacy Use Cases

• Document : IHE Pharmacy Hospital Use Cases v04
• Assumption :
  • Hospital pharmacy Use Cases and transactions will be aligned with IHE Use Cases/ transactions of other hospital departments
  • IHE/Scheduled Workflow centric actors : order filler = prescriber
• Feedback :
• Prioritize the Use Cases so that the realization fit in the 18 monts time interval of IHE. *** year1 priorities : basic prescription, simple substitution use case , exit medication (as consistency check between community and hospital pharmacy actors)
  • year2+ priorities : complicated substitution use case, injectable follow*up use case,…
  • Align terms with community pharmacy use cases :
    • Rename “picking and dose preparation” actor into dispenser actor
    • Rename Administration by “Medication administration manager”
  • Add formulary = list of medication (+permission rules) in hospital; used for substitution
  • Define the actor in terms of its responsibilities and need in terms of the actions that he performs. Include possible realizations for clarification

IHE Pharmacy domain

• The current IHE Europe – Pharmacy workgroup will evolve to a new global IHE Pharmacy domain that will take ownership for creating the technical specifications with the current Use Cases as input.
• The creation of the IHE Pharmacy domain will consists of the following steps :
  • Identification of primarily users, vendors and sponsoring organizations (e.g. hospital pharmacy associations like EAHP, ASHP)
  • Submission of application form that details scope, members/sponsors, roadmap ,,
    • Action : G. Claeys will circulate a 1st draft before mid July
  • IHE International will review the application form and will make a go/no go decision : +* august
• IHE follows a development heartbeat of 18 months * from initial use case to testing of implementations at connectathons
• Timing :
  • September 2008 : completion of Use Cases
  • July 2009 : completion of Technical Framework
  • Spring 2010 : test implementations at connectathons

Miscellaneous

• Intellectual Property: according to the IHE Governance document (http://www.ihe.net/governance/) is IHE the owner of all of produced documents. Contributors/editors have to sign the IHE membership agreement.
• In order to remain neutral, IHE forbids the publication of organization logos in their publications. However, many IHE documents contains a list of supporting organizations in their introduction section.
• Potential new members : UK , Germany [hospital pharmacist]

Next Steps

• Complete the Use Case descriptions, including actors and transactions.
  • Target date : End september 2009
  • Action :
    • Editors : incorporate feedback
    • Documents will be completed during the 2 days workshop in September

Timing

• June 2008 : Finalise main Use Case; submit to global IHE Development committee
• Mid 2008 – Mid 2009 : profile development (as global IHE Pharmacy committee)
• 2010 : Test IHE Pharmacy implementations at connectathons